In this week’s Medical Minute, new developments in “cell reprogramming” that could help patients recover from spinal cord injuries which lead to permanent paralysis in the past. 

Long-term care options are expensive and often out of reach for elders and people with disabilities. Part of the president's proposed infrastructure plan would help fund home-based health services.

An ear made from an apple, a spinal cord rebuilt using asparagus...it sounds like bizarre science fiction. But Andrew Pelling is working on a way to revive human tissue with a trip to the supermarket.

The European Medicines Agency says there is a possible link between the AstraZeneca COVID vaccine and rare blood clots.

Researchers are reporting some progress in their search for drugs that tamp down the overwhelming immune reaction that can kill a patient with COVID-19.

The three vaccines available in the U.S. are safe and effective, but not ideal. Now, work is underway to create more convenient and potent vaccines, including a tablet and nasal spray.

A medical team in New York City says it has performed the first complete surgical transplant of a trachea. These kinds of transplants are one of the last big transplant challenges.

This week’s Medical Minute, discusses cystic fibrosis research into how nutrition, body composition and exercise play in patients’ health across an increasing lifespan. One major goal is to better pinpoint who will develop CF-related diabetes.

An experiment that induced imaginary sounds in both people and mice could help explain how brain disorders like schizophrenia cause hallucinations.

The possibility that vaccines meant to prevent the disease may also be a treatment for long COVID — when symptoms linger for months — has sparked optimism among patients and scientists.

One smart way of getting the vaccine to communities at high risk of COVID-19: Take it to places many patients already visit three times a week.

This week’s Medical Minute, discusses a manmade molecule called “givinostat” that coaxes stem cells, which have the potential to become any cell type, to become “muscle progenitor cells”, which are useful for recovery from injuries, and the loss of muscle mass that comes with aging.

Same building. Same procedure. Same doctor. But there was an extra "facility fee" because the location changed slightly. A shot that used to cost her about $30 went up to more than $300.

There's no link between COVID-19 vaccines and death. But a new NPR analysis finds stories implying a connection have gone viral this year at a dramatic rate.

Getting the COVID-19 vaccine into most Americans' arms will involve much more than a good supply and logistics. Values such as equity, deep listening, and informed choice are crucial, too.